Cite
HARVARD Citation
Picozzi, V. et al. (n.d.). 90Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies. European journal of cancer. 51 (14), pp. 1857-1864. [Online].